These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 21668964
1. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, Auricchio A. J Cardiovasc Magn Reson; 2011 Jun 13; 13(1):29. PubMed ID: 21668964 [Abstract] [Full Text] [Related]
2. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. Bose A, Kandala J, Upadhyay GA, Riedl L, Ahmado I, Padmanabhan R, Gewirtz H, Mulligan LJ, Singh JP. J Cardiovasc Electrophysiol; 2014 May 13; 25(5):507-513. PubMed ID: 24350650 [Abstract] [Full Text] [Related]
3. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study. Taylor RJ, Umar F, Panting JR, Stegemann B, Leyva F. Heart Rhythm; 2016 Feb 13; 13(2):481-9. PubMed ID: 26498258 [Abstract] [Full Text] [Related]
14. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. Alpendurada F, Guha K, Sharma R, Ismail TF, Clifford A, Banya W, Mohiaddin RH, Pennell DJ, Cowie MR, McDonagh T, Prasad SK. J Cardiovasc Magn Reson; 2011 Oct 31; 13(1):68. PubMed ID: 22040270 [Abstract] [Full Text] [Related]
15. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S, Bluemke DA, Gerstenblith G, Marbán E, Tomaselli GF, Lima JA. J Am Coll Cardiol; 2008 Jun 24; 51(25):2414-21. PubMed ID: 18565399 [Abstract] [Full Text] [Related]
17. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study. Laksman Z, Yee R, Stirrat J, Gula LJ, Skanes AC, Leong-Sit P, Manlucu J, McCarty D, Turkistani Y, Scholl D, Rajchl M, Goela A, Islam A, Thompson RT, Drangova M, White JA. Circ Arrhythm Electrophysiol; 2014 Dec 24; 7(6):1040-7. PubMed ID: 25221334 [Abstract] [Full Text] [Related]
19. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure. Wong TC, Piehler KM, Zareba KM, Lin K, Phrampus A, Patel A, Moon JC, Ugander M, Valeti U, Holtz JE, Fu B, Chang CC, Mathier M, Kellman P, Butler J, Gheorghiade M, Schelbert EB. J Am Heart Assoc; 2013 Nov 18; 2(6):e000416. PubMed ID: 24249712 [Abstract] [Full Text] [Related]
20. Female gender is associated with a better outcome after cardiac resynchronization therapy. Leyva F, Foley PW, Chalil S, Irwin N, Smith RE. Pacing Clin Electrophysiol; 2011 Jan 18; 34(1):82-8. PubMed ID: 21214589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]